A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma

BACKGROUND: The World Health Organization recommends at least 3 annual antibiotic mass drug administrations (MDA) where the prevalence of trachoma is >10% in children ages 1–9 years, with coverage at least at 80%. However, the additional value of higher coverage targeted at children with multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Sheila K., Bailey, Robin, Munoz, Beatriz, Edwards, Tansy, Mkocha, Harran, Gaydos, Charlotte, Lietman, Thomas, Porco, Travis, Mabey, David, Quinn, Thomas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757067/
https://www.ncbi.nlm.nih.gov/pubmed/24009792
http://dx.doi.org/10.1371/journal.pntd.0002415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757067/
https://www.ncbi.nlm.nih.gov/pubmed/24009792
http://dx.doi.org/10.1371/journal.pntd.0002415

Ejemplares similares